1. Ananth, J. (1982) Benzodiazepines: Selective use to avoid addiction.Postgraduate Med
72, 271–276.
2. Barnett, A., Goldstein, J., Fiedler, E., and Taber, R. (1975) Etonitazene- induced rigidity and its antagonism by centrally acting muscle relaxants. Eur. J. Pharmacol.
30, 23–28.
3. Beer, B. and Migler, B. (1975) Effects of Diazepam on Galvanic Skin Response and Conflict in Monkeys and Humans, in Predictability in Psychopharmacology: Preclinical and Clinical Correlations ( Sudilovsky, A., Gershon, S., and Beer, B., eds.) Raven, New York.
4. Bernard, P, Bergen, K„ Sobiski, R., and Robson, R. (1981) CGS 8216 (2-phenylpyrazolo) [4,3-c] quinolin-3(5Hl)-one), an orally effective benzodiazepine antagonist. Pharmacologist
23, 150.
5. Bernard, P. S., Bennett, D. A., Pastor, G., Yokoyama, N., and Liebman, J. M. (1985) CGS 9896: Agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents. J. Pharmacol. Exp. Ther.
235, 98–105.